Alpha Sense BI

AUGUST 30, 2023

As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027.

Management 98

Management Biotech Due Diligence Algorithm 98

Fuld

NOVEMBER 1, 2022

BOSTON – Nov 1, 2022 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Brad Thompson to the role of Advisory Board Member. Joining Fuld & Company is an exciting opportunity for me to work with global leaders in research, analytics, and intelligence ,” says Brad.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

Alpha Sense BI

MAY 5, 2023

2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech.

Biotech 97

Biotech Capital Banking Startups 97

CIO

DECEMBER 27, 2023

These countries offer competitive salaries, a lower cost of living compared to other major tech hubs, and better opportunities for quality of life and work-life balance. A survey from global talent marketplace Andela found that 88% of enterprise companies are looking for top tech talent in other countries.

Startups 860

Startups Biotech Capital Innovation 860

Alpha Sense BI

APRIL 29, 2024

This staggering statistic is representative of a transformative shift in the asset management space away from archaic research methods. Generative AI in venture capital streamlines workflows, reduces research and due diligence blind spots, and surfaces qualitative and quantitative insights to make data-driven decisions faster.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

APRIL 19, 2024

2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e. OpenAI’s ChatGPT ). Having proven to be a catalyst for business growth, genAI is projected to boast a $1.3 billion by 2030 with a CAGR of 23.1%

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. In the age of information overload, you need reliable resources of insights to act quickly.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

APRIL 12, 2024

Expert interviews are a critical primary research tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. You think, ‘I have competitively a better methodology, a better framework, and you think the world will go on it.’ Similarly, expert calls fill particular roles.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

CIO

JULY 17, 2023

Many IT leaders today are focused more on security management as well as improving IT operations and systems performance than they are on top-line and strategic activities such as driving business innovation, identifying competitive differentiation opportunities, and even working on business strategy.

Biotech 617

Biotech Innovation Technology Technology 617

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. while completing his postdoctoral research work with the University of California. Adi received his B.S.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

NOVEMBER 9, 2022

Customers have multiyear R&D product road maps, and the competitive environment for customers is more challenging today than it’s ever been. M&A IPOs to watch in Pharma and Biotech. Annaliesa Anderson, Senior VP and Chief Scientific Officer for Bacterial Vaccines – Vaccine Research & Development Unit.

Sales 52

Sales Loss Capital Biotech 52

Alpha Sense BI

MARCH 13, 2024

billion acquisition of Carmot Therapeutics, a clinical-stage biotechnology company with three GLP-1 assets in clinical production, including its CT-388 lead GLP-1 asset, in the hopes of gaining a competitive footing among Novo Nordisk and Eli Lilly’s products currently on the market (Ozempic, Wegovy, and Mounjaro, respectively).

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their market research, landscaping, and monitoring. Some are equipped with artificial intelligence capabilities that enable you to maximize and streamline your research, while others are more traditional in their approach.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Happy Market

MAY 9, 2022

Founded in 2007, Civic Science is a consumer intelligence research platform that polls millions of Americans each week covering thousands of topics. HubUX is a research operation platform for private panel management, qualitative automation including video audition questions, and surveys. Happy Researching! ??. [00:00:00].

Management 52

Management Entertainment Market Research Marketing Research 52